カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Basiliximab Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19170）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19170
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：73
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

バシリキシマブ注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のバシリキシマブ注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

バシリキシマブ注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・20mL、10mL

用途別セグメントは次のように区分されます。
・成人用、小児用

世界のバシリキシマブ注射市場の主要な市場プレーヤーは以下のとおりです。
・Novartis AG、Ryvis Pharma

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、バシリキシマブ注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なバシリキシマブ注射メーカーの企業概要、2019年～2022年までのバシリキシマブ注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なバシリキシマブ注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別バシリキシマブ注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのバシリキシマブ注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのバシリキシマブ注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびバシリキシマブ注射の産業チェーンを掲載しています。
・第13、14、15章では、バシリキシマブ注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- バシリキシマブ注射の概要
- 種類別分析（2017年vs2021年vs2028年）：20mL、10mL
- 用途別分析（2017年vs2021年vs2028年）：成人用、小児用
- 世界のバシリキシマブ注射市場規模・予測
- 世界のバシリキシマブ注射生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis AG、Ryvis Pharma
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：20mL、10mL
・用途別分析2017年-2028年：成人用、小児用
・バシリキシマブ注射の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・バシリキシマブ注射のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・バシリキシマブ注射のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・バシリキシマブ注射の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・バシリキシマブ注射の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Basiliximab Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Basiliximab Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Adult Use accounting for % of the Basiliximab Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 20 mL segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Basiliximab Injection include Novartis AG, Ryvis Pharma, , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Basiliximab Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
20 mL
10 mL
Market segment by Application can be divided into
Adult Use
Pediatric Use
The key market players for global Basiliximab Injection market are listed below:
Novartis AG
Ryvis Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Basiliximab Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Basiliximab Injection, with price, sales, revenue and global market share of Basiliximab Injection from 2019 to 2022.
Chapter 3, the Basiliximab Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Basiliximab Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Basiliximab Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Basiliximab Injection.
Chapter 13, 14, and 15, to describe Basiliximab Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Basiliximab Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Basiliximab Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 20 mL
1.2.3 10 mL
1.3 Market Analysis by Application
1.3.1 Overview: Global Basiliximab Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Adult Use
1.3.3 Pediatric Use
1.4 Global Basiliximab Injection Market Size & Forecast
1.4.1 Global Basiliximab Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Basiliximab Injection Sales in Volume (2017-2028)
1.4.3 Global Basiliximab Injection Price (2017-2028)
1.5 Global Basiliximab Injection Production Capacity Analysis
1.5.1 Global Basiliximab Injection Total Production Capacity (2017-2028)
1.5.2 Global Basiliximab Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Basiliximab Injection Market Drivers
1.6.2 Basiliximab Injection Market Restraints
1.6.3 Basiliximab Injection Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Basiliximab Injection Product and Services
2.1.4 Novartis AG Basiliximab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ryvis Pharma
2.2.1 Ryvis Pharma Details
2.2.2 Ryvis Pharma Major Business
2.2.3 Ryvis Pharma Basiliximab Injection Product and Services
2.2.4 Ryvis Pharma Basiliximab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Basiliximab Injection Breakdown Data by Manufacturer
3.1 Global Basiliximab Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Basiliximab Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Basiliximab Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Basiliximab Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Basiliximab Injection Manufacturer Market Share in 2021
3.5 Global Basiliximab Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Basiliximab Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Basiliximab Injection Market Size by Region
4.1.1 Global Basiliximab Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Basiliximab Injection Revenue by Region (2017-2028)
4.2 North America Basiliximab Injection Revenue (2017-2028)
4.3 Europe Basiliximab Injection Revenue (2017-2028)
4.4 Asia-Pacific Basiliximab Injection Revenue (2017-2028)
4.5 South America Basiliximab Injection Revenue (2017-2028)
4.6 Middle East and Africa Basiliximab Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Basiliximab Injection Sales in Volume by Type (2017-2028)
5.2 Global Basiliximab Injection Revenue by Type (2017-2028)
5.3 Global Basiliximab Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Basiliximab Injection Sales in Volume by Application (2017-2028)
6.2 Global Basiliximab Injection Revenue by Application (2017-2028)
6.3 Global Basiliximab Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Basiliximab Injection Sales by Type (2017-2028)
7.2 North America Basiliximab Injection Sales by Application (2017-2028)
7.3 North America Basiliximab Injection Market Size by Country
7.3.1 North America Basiliximab Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Basiliximab Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Basiliximab Injection Sales by Type (2017-2028)
8.2 Europe Basiliximab Injection Sales by Application (2017-2028)
8.3 Europe Basiliximab Injection Market Size by Country
8.3.1 Europe Basiliximab Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Basiliximab Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Basiliximab Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Basiliximab Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Basiliximab Injection Market Size by Region
9.3.1 Asia-Pacific Basiliximab Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Basiliximab Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Basiliximab Injection Sales by Type (2017-2028)
10.2 South America Basiliximab Injection Sales by Application (2017-2028)
10.3 South America Basiliximab Injection Market Size by Country
10.3.1 South America Basiliximab Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Basiliximab Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Basiliximab Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Basiliximab Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Basiliximab Injection Market Size by Country
11.3.1 Middle East & Africa Basiliximab Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Basiliximab Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Basiliximab Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Basiliximab Injection
12.3 Basiliximab Injection Production Process
12.4 Basiliximab Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Basiliximab Injection Typical Distributors
13.3 Basiliximab Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Basiliximab Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Basiliximab Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Basiliximab Injection Product and Services
Table 6. Novartis AG Basiliximab Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ryvis Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Ryvis Pharma Major Business
Table 9. Ryvis Pharma Basiliximab Injection Product and Services
Table 10. Ryvis Pharma Basiliximab Injection Sales (KL), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Global Basiliximab Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (KL)
Table 12. Global Basiliximab Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 13. Market Position of Manufacturers in Basiliximab Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 14. Global Basiliximab Injection Production Capacity by Company, (KL): 2020 VS 2021
Table 15. Head Office and Basiliximab Injection Production Site of Key Manufacturer
Table 16. Basiliximab Injection New Entrant and Capacity Expansion Plans
Table 17. Basiliximab Injection Mergers & Acquisitions in the Past Five Years
Table 18. Global Basiliximab Injection Sales by Region (2017-2022) & (KL)
Table 19. Global Basiliximab Injection Sales by Region (2023-2028) & (KL)
Table 20. Global Basiliximab Injection Revenue by Region (2017-2022) & (USD Million)
Table 21. Global Basiliximab Injection Revenue by Region (2023-2028) & (USD Million)
Table 22. Global Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 23. Global Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 24. Global Basiliximab Injection Revenue by Type (2017-2022) & (USD Million)
Table 25. Global Basiliximab Injection Revenue by Type (2023-2028) & (USD Million)
Table 26. Global Basiliximab Injection Price by Type (2017-2022) & (US$/L)
Table 27. Global Basiliximab Injection Price by Type (2023-2028) & (US$/L)
Table 28. Global Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 29. Global Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 30. Global Basiliximab Injection Revenue by Application (2017-2022) & (USD Million)
Table 31. Global Basiliximab Injection Revenue by Application (2023-2028) & (USD Million)
Table 32. Global Basiliximab Injection Price by Application (2017-2022) & (US$/L)
Table 33. Global Basiliximab Injection Price by Application (2023-2028) & (US$/L)
Table 34. North America Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 35. North America Basiliximab Injection Sales by Country (2023-2028) & (KL)
Table 36. North America Basiliximab Injection Revenue by Country (2017-2022) & (USD Million)
Table 37. North America Basiliximab Injection Revenue by Country (2023-2028) & (USD Million)
Table 38. North America Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 39. North America Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 40. North America Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 41. North America Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 42. Europe Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 43. Europe Basiliximab Injection Sales by Country (2023-2028) & (KL)
Table 44. Europe Basiliximab Injection Revenue by Country (2017-2022) & (USD Million)
Table 45. Europe Basiliximab Injection Revenue by Country (2023-2028) & (USD Million)
Table 46. Europe Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 47. Europe Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 48. Europe Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 49. Europe Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 50. Asia-Pacific Basiliximab Injection Sales by Region (2017-2022) & (KL)
Table 51. Asia-Pacific Basiliximab Injection Sales by Region (2023-2028) & (KL)
Table 52. Asia-Pacific Basiliximab Injection Revenue by Region (2017-2022) & (USD Million)
Table 53. Asia-Pacific Basiliximab Injection Revenue by Region (2023-2028) & (USD Million)
Table 54. Asia-Pacific Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 55. Asia-Pacific Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 56. Asia-Pacific Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 57. Asia-Pacific Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 58. South America Basiliximab Injection Sales by Country (2017-2022) & (KL)
Table 59. South America Basiliximab Injection Sales by Country (2023-2028) & (KL)
Table 60. South America Basiliximab Injection Revenue by Country (2017-2022) & (USD Million)
Table 61. South America Basiliximab Injection Revenue by Country (2023-2028) & (USD Million)
Table 62. South America Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 63. South America Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 64. South America Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 65. South America Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 66. Middle East & Africa Basiliximab Injection Sales by Region (2017-2022) & (KL)
Table 67. Middle East & Africa Basiliximab Injection Sales by Region (2023-2028) & (KL)
Table 68. Middle East & Africa Basiliximab Injection Revenue by Region (2017-2022) & (USD Million)
Table 69. Middle East & Africa Basiliximab Injection Revenue by Region (2023-2028) & (USD Million)
Table 70. Middle East & Africa Basiliximab Injection Sales by Type (2017-2022) & (KL)
Table 71. Middle East & Africa Basiliximab Injection Sales by Type (2023-2028) & (KL)
Table 72. Middle East & Africa Basiliximab Injection Sales by Application (2017-2022) & (KL)
Table 73. Middle East & Africa Basiliximab Injection Sales by Application (2023-2028) & (KL)
Table 74. Basiliximab Injection Raw Material
Table 75. Key Manufacturers of Basiliximab Injection Raw Materials
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Basiliximab Injection Typical Distributors
Table 79. Basiliximab Injection Typical Customers
List of Figures
Figure 1. Basiliximab Injection Picture
Figure 2. Global Basiliximab Injection Revenue Market Share by Type in 2021
Figure 3. 20 mL
Figure 4. 10 mL
Figure 5. Global Basiliximab Injection Revenue Market Share by Application in 2021
Figure 6. Adult Use
Figure 7. Pediatric Use
Figure 8. Global Basiliximab Injection Revenue, (USD Million) & (KL): 2017 & 2021 & 2028
Figure 9. Global Basiliximab Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Basiliximab Injection Sales (2017-2028) & (KL)
Figure 11. Global Basiliximab Injection Price (2017-2028) & (US$/L)
Figure 12. Global Basiliximab Injection Production Capacity (2017-2028) & (KL)
Figure 13. Global Basiliximab Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Basiliximab Injection Market Drivers
Figure 15. Basiliximab Injection Market Restraints
Figure 16. Basiliximab Injection Market Trends
Figure 17. Global Basiliximab Injection Sales Market Share by Manufacturer in 2021
Figure 18. Global Basiliximab Injection Revenue Market Share by Manufacturer in 2021
Figure 19. Basiliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Basiliximab Injection Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Basiliximab Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Basiliximab Injection Sales Market Share by Region (2017-2028)
Figure 23. Global Basiliximab Injection Revenue Market Share by Region (2017-2028)
Figure 24. North America Basiliximab Injection Revenue (2017-2028) & (USD Million)
Figure 25. Europe Basiliximab Injection Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Basiliximab Injection Revenue (2017-2028) & (USD Million)
Figure 27. South America Basiliximab Injection Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Basiliximab Injection Revenue (2017-2028) & (USD Million)
Figure 29. Global Basiliximab Injection Sales Market Share by Type (2017-2028)
Figure 30. Global Basiliximab Injection Revenue Market Share by Type (2017-2028)
Figure 31. Global Basiliximab Injection Price by Type (2017-2028) & (US$/L)
Figure 32. Global Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 33. Global Basiliximab Injection Revenue Market Share by Application (2017-2028)
Figure 34. Global Basiliximab Injection Price by Application (2017-2028) & (US$/L)
Figure 35. North America Basiliximab Injection Sales Market Share by Type (2017-2028)
Figure 36. North America Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 37. North America Basiliximab Injection Sales Market Share by Country (2017-2028)
Figure 38. North America Basiliximab Injection Revenue Market Share by Country (2017-2028)
Figure 39. United States Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Basiliximab Injection Sales Market Share by Type (2017-2028)
Figure 43. Europe Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 44. Europe Basiliximab Injection Sales Market Share by Country (2017-2028)
Figure 45. Europe Basiliximab Injection Revenue Market Share by Country (2017-2028)
Figure 46. Germany Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Basiliximab Injection Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Basiliximab Injection Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Basiliximab Injection Revenue Market Share by Region (2017-2028)
Figure 55. China Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Basiliximab Injection Sales Market Share by Type (2017-2028)
Figure 62. South America Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 63. South America Basiliximab Injection Sales Market Share by Country (2017-2028)
Figure 64. South America Basiliximab Injection Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Basiliximab Injection Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Basiliximab Injection Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Basiliximab Injection Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Basiliximab Injection Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Basiliximab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Basiliximab Injection in 2021
Figure 76. Manufacturing Process Analysis of Basiliximab Injection
Figure 77. Basiliximab Injection Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
  • 世界のヴェノファー（鉄ショ糖注射液）市場2022年：市場規模予測（～2028年）
  • 世界のビンクリスチン硫酸リポソーム注射市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19170 )"世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）" (英文：Global Basiliximab Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。